Review of the Protective Mechanism of Curcumin on Cardiovascular Disease

References

• Heidenreich PA, Trogdon JG, Khavjou OA, et al. Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation. 2011;123(8):933–944. doi:10.1161/CIR.0b013e31820a55f5
   PubMed Web of Science ®Google Scholar
• Kim BM. The role of saikosaponins in therapeutic strategies for age-related diseases. Oxid Med Cell Longev. 2018;2018:8275256. doi:10.1155/2018/8275256
   PubMed Web of Science ®Google Scholar
• Campbell MS, Fleenor BS. The emerging role of curcumin for improving vascular dysfunction: a review. Crit Rev Food Sci Nutr. 2018;58(16):2790–2799. doi:10.1080/10408398.2017.1341865
   PubMed Web of Science ®Google Scholar
• Li H, Sureda A, Devkota HP, et al. Curcumin, the golden spice in treating cardiovascular diseases. Biotechnol Adv. 2020;38:107343. doi:10.1016/j.biotechadv.2019.01.010
   PubMed Web of Science ®Google Scholar
• Madamanchi NR, Hakim ZS, Runge MS. Oxidative stress in atherogenesis and arterial thrombosis: the disconnect between cellular studies and clinical outcomes. J Thromb Haemost. 2005;3(2):254–267. doi:10.1111/j.1538-7836.2004.01085.x
   PubMed Web of Science ®Google Scholar
• Nie P, Meng F, Zhang J, et al. Astragaloside IV exerts a myocardial protective effect against cardiac hypertrophy in rats, partially via activating the Nrf2/HO-1 signaling pathway. Oxid Med Cell Longev. 2019;2019:4625912. doi:10.1155/2019/4625912
   PubMed Web of Science ®Google Scholar
• Zhou X, Afzal S, Zheng YF, et al. Synergistic protective effect of curcumin and resveratrol against oxidative stress in endothelial EA.hy926 cells. Evid Based Complement Alternat Med. 2021;2021:2661025. doi:10.1155/2021/2661025
   PubMed Web of Science ®Google Scholar
• Yang Y, Duan W, Liang Z, et al. Curcumin attenuates endothelial cell oxidative stress injury through Notch signaling inhibition. Cell Signal. 2013;25(3):615–629. doi:10.1016/j.cellsig.2012.11.025
   PubMed Web of Science ®Google Scholar
• Ouyang J, Li R, Shi H, et al. Curcumin protects human umbilical vein endothelial cells against H2 O2 -induced cell injury. Pain Res Manag. 2019;2019:3173149. doi:10.1155/2019/3173149
   PubMed Web of Science ®Google Scholar
• Lan C, Chen X, Zhang Y, et al. Curcumin prevents strokes in stroke-prone spontaneously hypertensive rats by improving vascular endothelial function. BMC Cardiovasc Disord. 2018;18(1):43. doi:10.1186/s12872-018-0768-6
   PubMedGoogle Scholar
• Boonla O, Kukongviriyapan U, Pakdeechote P, et al. Curcumin improves endothelial dysfunction and vascular remodeling in 2K-1C hypertensive rats by raising nitric oxide availability and reducing oxidative stress. Nitric Oxide. 2014;42:44–53. doi:10.1016/j.niox.2014.09.001
   PubMed Web of Science ®Google Scholar
• Rungseesantivanon S, Thenchaisri N, Ruangvejvorachai P, et al. Curcumin supplementation could improve diabetes-induced endothelial dysfunction associated with decreased vascular superoxide production and PKC inhibition. BMC Complement Altern Med. 2010;10:57. doi:10.1186/1472-6882-10-57
   PubMed Web of Science ®Google Scholar
• Wu T, Xiang Y, Lv Y, Li D, Yu L, Guo R. miR-590-3p mediates the protective effect of curcumin on injured endothelial cells induced by angiotensin II. Am J Transl Res. 2017;9(2):289–300.
   PubMed Web of Science ®Google Scholar
• Zhang S, Zou J, Li P, et al. Curcumin Protects against Atherosclerosis in Apolipoprotein E-Knockout Mice by Inhibiting Toll-like Receptor 4 Expression. J Agric Food Chem. 2018;66(2):449–456. doi:10.1021/acs.jafc.7b04260
   PubMed Web of Science ®Google Scholar
• Kim DC, Lee W, Bae JS. Vascular anti-inflammatory effects of curcumin on HMGB1-mediated responses in vitro. Inflamm Res. 2011;60(12):1161–1168. doi:10.1007/s00011-011-0381-y
   PubMed Web of Science ®Google Scholar
• Lv YL, Jia Y, Wan Z, et al. Curcumin inhibits the formation of atherosclerosis in ApoE-/- mice by suppressing cytomegalovirus activity in endothelial cells. Life Sci. 2020;257:117658. doi:10.1016/j.lfs.2020.117658
   PubMed Web of Science ®Google Scholar
• Chen D, Zhu C, Ye S, et al. Curcumin ameliorates oxidized low-density lipoprotein (ox-LDL)-caused damage in human umbilical vein endothelial cells (HUVECs) through the miR-599/MYD88/NF-κB axis. Toxicol In Vitro. 2022;85:105481. doi:10.1016/j.tiv.2022.105481
   PubMed Web of Science ®Google Scholar
• Wan Q, Liu ZY, Yang YP, et al. Effect of curcumin on inhibiting atherogenesis by down-regulating lipocalin-2 expression in apolipoprotein E knockout mice. Biomed Mater Eng. 2016;27(6):577–587. doi:10.3233/BME-161610
   PubMed Web of Science ®Google Scholar
• Pirvulescu MM, Gan AM, Stan D, et al. Curcumin and a Morus alba extract reduce pro-inflammatory effects of resistin in human endothelial cells. Phytother Res. 2011;25(12):1737–1742. doi:10.1002/ptr.3463
   PubMed Web of Science ®Google Scholar
• Xiao Y, Xia J, Wu S, et al. Curcumin inhibits acute vascular inflammation through the activation of heme oxygenase-1. Oxid Med Cell Longev. 2018;2018:3295807. doi:10.1155/2018/3295807
   PubMed Web of Science ®Google Scholar
• Olszanecki R, Gebska A, Korbut R. The role of haem oxygenase-1 in the decrease of endothelial intercellular adhesion molecule-1 expression by curcumin. Basic Clin Pharmacol Toxicol. 2007;101(6):411–415. doi:10.1111/j.1742-7843.2007.00151.x
   PubMed Web of Science ®Google Scholar
• Wongeakin N, Bhattarakosol P, Patumraj S. Molecular mechanisms of curcumin on diabetes-induced endothelial dysfunctions: txnip, ICAM-1, and NOX2 expressions. Biomed Res Int. 2014;2014:161346. doi:10.1155/2014/161346
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li K. Curcumin attenuates high glucose-induced inflammatory injury through the reactive oxygen species-phosphoinositide 3-kinase/protein kinase B-nuclear factor-κB signaling pathway in rat thoracic aorta endothelial cells. J Diabetes Investig. 2018;9(4):731–740. doi:10.1111/jdi.12767
   PubMed Web of Science ®Google Scholar
• Sun YP, Gu JF, Tan XB, et al. Curcumin inhibits advanced glycation end product-induced oxidative stress and inflammatory responses in endothelial cell damage via trapping methylglyoxal. Mol Med Rep. 2016;13(2):1475–1486. doi:10.3892/mmr.2015.4725
   PubMed Web of Science ®Google Scholar
• Hu TY, Liu CL, Chyau CC, et al. Trapping of methylglyoxal by curcumin in cell-free systems and in human umbilical vein endothelial cells. J Agric Food Chem. 2012;60(33):8190–8196. doi:10.1021/jf302188a
   PubMed Web of Science ®Google Scholar
• Narra SS, Rosanaly S, Rondeau P, et al. ApoA-I nanoparticles as curcumin carriers for cerebral endothelial cells: improved cytoprotective effects against methylglyoxal. Pharmaceuticals (Basel). 2022;15(3):347. doi:10.3390/ph15030347
   PubMedGoogle Scholar
• Sowndhar Rajan B, Krishnan K, Vellaichamy E. Diet-derived advanced glycation end products (dAGEs) induce proinflammatory cytokine expression in cardiac and renal tissues of experimental mice: protective effect of curcumin. Cardiovasc Toxicol. 2022;22(1):35–51. doi:10.1007/s12012-021-09697-4
   PubMed Web of Science ®Google Scholar
• Li J, Luo M, Xie N, Wang J, Chen L. Curcumin protects endothelial cells against homocysteine induced injury through inhibiting inflammation. Am J Transl Res. 2016;8(11):4598–4604.
   PubMed Web of Science ®Google Scholar
• Lee SE, Park HR, Jeon S, Han D, Park YS. Curcumin attenuates acrolein-induced COX-2 expression and prostaglandin production in human umbilical vein endothelial cells. J Lipid Atheroscler. 2020;9(1):184–194. doi:10.12997/jla.2020.9.1.184
   PubMedGoogle Scholar
• Chen D, Weng L, Chen C, et al. Inflammation and dysfunction in human aortic endothelial cells associated with poly-l-lactic acid degradation in vitro are alleviated by curcumin. J Biomed Mater Res A. 2019;107(12):2756–2763. doi:10.1002/jbm.a.36778
   PubMed Web of Science ®Google Scholar
• Li X, Xiao H, Lin C, et al. Synergistic effects of liposomes encapsulating atorvastatin calcium and curcumin and targeting dysfunctional endothelial cells in reducing atherosclerosis. Int J Nanomed. 2019;14:649–665. doi:10.2147/IJN.S189819
   PubMed Web of Science ®Google Scholar
• Panicker SR, Kartha CC. Curcumin attenuates glucose-induced monocyte chemoattractant protein-1 synthesis in aortic endothelial cells by modulating the nuclear factor-kappaB pathway. Pharmacology. 2010;85(1):18–26. doi:10.1159/000262325
   PubMed Web of Science ®Google Scholar
• Monfoulet LE, Mercier S, Bayle D, et al. Curcumin modulates endothelial permeability and monocyte transendothelial migration by affecting endothelial cell dynamics. Free Radic Biol Med. 2017;112:109–120. doi:10.1016/j.freeradbiomed.2017.07.019
   PubMed Web of Science ®Google Scholar
• Lee HS, Lee MJ, Kim H, et al. Curcumin inhibits TNFalpha-induced lectin-like oxidised LDL receptor-1 (LOX-1) expression and suppresses the inflammatory response in human umbilical vein endothelial cells (HUVECs) by an antioxidant mechanism. J Enzyme Inhib Med Chem. 2010;25(5):720–729. doi:10.3109/14756360903555274
   PubMed Web of Science ®Google Scholar
• Soltani B, Bodaghabadi N, Mahpour G, et al. Nanoformulation of curcumin protects HUVEC endothelial cells against ionizing radiation and suppresses their adhesion to monocytes: potential in prevention of radiation-induced atherosclerosis. Biotechnol Lett. 2016;38(12):2081–2088. doi:10.1007/s10529-016-2189-x
   PubMed Web of Science ®Google Scholar
• Zingg JM, Hasan ST, Nakagawa K, et al. Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression. Biofactors. 2017;43(1):42–53. doi:10.1002/biof.1307
   PubMed Web of Science ®Google Scholar
• Tian N, Li X, Luo Y, et al. Curcumin regulates the metabolism of low density lipoproteins by improving the C-to-U RNA editing efficiency of apolipoprotein B in primary rat hepatocytes. Mol Med Rep. 2014;9(1):132–136. doi:10.3892/mmr.2013.1754
   PubMed Web of Science ®Google Scholar
• Altinel Y, Kose E, Karacaglar A, et al. Systemic Amelioration via Curcumin in Rats following Splenectomy: lipid Profile, Endothelial and Oxidative Damage. J Invest Surg. 2021;34(6):627–636. doi:10.1080/08941939.2020.1834651
   PubMed Web of Science ®Google Scholar
• Zhao JF, Ching LC, Huang YC, et al. Molecular mechanism of curcumin on the suppression of cholesterol accumulation in macrophage foam cells and atherosclerosis. Mol Nutr Food Res. 2012;56(5):691–701. doi:10.1002/mnfr.201100735
   PubMed Web of Science ®Google Scholar
• Tan C, Zhou L, Wen W, et al. Curcumin promotes cholesterol efflux by regulating ABCA1 expression through miR-125a-5p/SIRT6 axis in THP-1 macrophage to prevent atherosclerosis. J Toxicol Sci. 2021;46(5):209–222. doi:10.2131/jts.46.209
   PubMed Web of Science ®Google Scholar
• Min KJ, Um HJ, Cho KH, et al. Curcumin inhibits ox-LDL-induced CD36 expression and foam cell formation through the inhibition of p38 MAPK phosphorylation. Food Chem Toxicol. 2013;58:77–85. doi:10.1016/j.fct.2013.04.008
   PubMed Web of Science ®Google Scholar
• Liu T, Li C, Sun H, et al. Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in macrophage. Inflamm Res. 2014;63(10):841–850. doi:10.1007/s00011-014-0758-9
   PubMed Web of Science ®Google Scholar
• Lin XL, Liu MH, Hu HJ, et al. Curcumin enhanced cholesterol efflux by upregulating ABCA1 expression through AMPK-SIRT1-LXRα signaling in THP-1 macrophage-derived foam cells. DNA Cell Biol. 2015;34(9):561–572. doi:10.1089/dna.2015.2866
   PubMed Web of Science ®Google Scholar
• Liu T, Li C, Sun H, et al. Curcumin inhibits monocyte chemoattractant protein-1 expression and enhances cholesterol efflux by suppressing the c-Jun N-terminal kinase pathway in macrophage. Inflamm Res. 2014;63(10):841–850.
   PubMed Web of Science ®Google Scholar
• Chen FY, Zhou J, Guo N, et al. Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis. Biochem Biophys Res Commun. 2015;467(4):872–878.
   PubMed Web of Science ®Google Scholar
• Ouyang S, Yao YH, Zhang ZM, et al. Curcumin inhibits hypoxia inducible factor-1α-induced inflammation and apoptosis in macrophages through an ERK dependent pathway. Eur Rev Med Pharmacol Sci. 2019;23(4):1816–1825. doi:10.26355/eurrev_201902_17145
   PubMed Web of Science ®Google Scholar
• Chen F, Guo N, Cao G, Zhou J, Yuan Z. Molecular analysis of curcumin-induced polarization of murine RAW264.7 macrophages. J Cardiovasc Pharmacol. 2014;63(6):544–552. doi:10.1097/FJC.0000000000000079
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhang T, Wang X, et al. Curcumin Modulates Macrophage Polarization Through the Inhibition of the Toll-Like Receptor 4 Expression and its Signaling Pathways. Cell Physiol Biochem. 2015;36(2):631–641. doi:10.1159/000430126
   PubMedGoogle Scholar
• Zhang J, Ou C, Chen M. Curcumin attenuates cadmium-induced atherosclerosis by regulating trimethylamine-N-oxide synthesis and macrophage polarization through remodeling the gut microbiota. Ecotoxicol Environ Saf. 2022;244:114057. doi:10.1016/j.ecoenv.2022.114057
   PubMed Web of Science ®Google Scholar
• Cao J, Ye B, Lin L, et al. Curcumin Alleviates ox-LDL Induced MMP-9 and EMMPRIN Expression through the Inhibition of NF-κB and MAPK Pathways in Macrophages. Front Pharmacol. 2017;8:62. doi:10.3389/fphar.2017.00062
   PubMed Web of Science ®Google Scholar
• Cao J, Han Z, Tian L, et al. Curcumin inhibits EMMPRIN and MMP-9 expression through AMPK-MAPK and PKC signaling in PMA induced macrophages. J Transl Med. 2014;12:266. doi:10.1186/s12967-014-0266-2
   PubMed Web of Science ®Google Scholar
• Zhou ZY, Chen YQ, Wang FY, et al. Effect of curcumin on down-expression of thrombospondin-4 induced by oxidized low-density lipoprotein in mouse macrophages. Biomed Mater Eng. 2014;24(1):181–189. doi:10.3233/BME-130798
   PubMed Web of Science ®Google Scholar
• Kadam S, Kanitkar M, Dixit K, et al. Curcumin reverses diabetes-induced endothelial progenitor cell dysfunction by enhancing MnSOD expression and activity in vitro and in vivo. J Tissue Eng Regen Med. 2018;12(7):1594–1607. doi:10.1002/term.2684
   PubMed Web of Science ®Google Scholar
• You J, Sun J, Ma T, et al. Curcumin induces therapeutic angiogenesis in a diabetic mouse hindlimb ischemia model via modulating the function of endothelial progenitor cells. Stem Cell Res Ther. 2017;8(1):182. doi:10.1186/s13287-017-0636-9
   PubMedGoogle Scholar
• Chen D, Tao X, Wang Y, et al. Curcumin accelerates reendothelialization and ameliorates intimal hyperplasia in balloon-injured rat carotid artery via the upregulation of endothelial cell autophagy. Int J Mol Med. 2015;36(6):1563–1571. doi:10.3892/ijmm.2015.2365
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang Q, Rao G, et al. Curcumin improves perfusion recovery in experimental peripheral arterial disease by upregulating microRNA-93 expression. Exp Ther Med. 2019;17(1):798–802. doi:10.3892/etm.2018.7000
   PubMed Web of Science ®Google Scholar
• Sagiroglu T, Kanter M, Yagci MA, et al. Protective effect of curcumin on cyclosporin A-induced endothelial dysfunction, antioxidant capacity, and oxidative damage. Toxicol Ind Health. 2014;30(4):316–327. doi:10.1177/0748233712456065
   PubMed Web of Science ®Google Scholar
• Sankrityayan H, Majumdar AS. Curcumin and folic acid abrogated methotrexate induced vascular endothelial dysfunction. Can J Physiol Pharmacol. 2016;94(1):89–96. doi:10.1139/cjpp-2015-0156
   PubMed Web of Science ®Google Scholar
• Guo N, Chen F, Zhou J, et al. Curcumin Attenuates Rapamycin-induced Cell Injury of Vascular Endothelial Cells. J Cardiovasc Pharmacol. 2015;66(4):338–346. doi:10.1097/FJC.0000000000000285
   PubMed Web of Science ®Google Scholar
• Chen D, Xi Y, Zhang S, et al. Curcumin attenuates inflammation of Macrophage-derived foam cells treated with Poly-L-lactic acid degradation via PPARγ signaling pathway. J Mater Sci Mater Med. 2022;33(4):33. doi:10.1007/s10856-022-06654-7
   PubMed Web of Science ®Google Scholar
• Shi J, Deng H, Zhang M. Curcumin pretreatment protects against PM2.5-induced oxidized low-density lipoprotein-mediated oxidative stress and inflammation in human microvascular endothelial cells. Mol Med Rep. 2017;16(3):2588–2594. doi:10.3892/mmr.2017.6935
   PubMed Web of Science ®Google Scholar
• Luo R, Zhao L, Li S, et al. Curcumin alleviates palmitic acid-induced LOX-1 upregulation by suppressing endoplasmic reticulum stress in HUVECs. Biomed Res Int. 2021;2021:9983725. doi:10.1155/2021/9983725
   PubMed Web of Science ®Google Scholar
• Han J, Pan XY, Xu Y, et al. Curcumin induces autophagy to protect vascular endothelial cell survival from oxidative stress damage. Autophagy. 2012;8(5):812–825. doi:10.4161/auto.19471
   PubMed Web of Science ®Google Scholar
• Guo S, Long M, Li X, et al. Curcumin activates autophagy and attenuates oxidative damage in EA.hy926 cells via the Akt/mTOR pathway. Mol Med Rep. 2016;13(3):2187–2193. doi:10.3892/mmr.2016.4796
   PubMed Web of Science ®Google Scholar
• Zhao L, Luo R, Yu H, et al. Curcumin protects human umbilical vein endothelial cells against high oxidized low density lipoprotein-induced lipotoxicity and modulates autophagy. Iran J Basic Med Sci. 2021;24(12):1734–1742. doi:10.22038/IJBMS.2021.59969.13297
   PubMed Web of Science ®Google Scholar
• Li X, Zhu R, Jiang H, et al. Autophagy enhanced by curcumin ameliorates inflammation in atherogenesis  via  the TFEB-P300-BRD4 axis. Acta Pharm Sin B. 2022;12(5):2280–2299. doi:10.1016/j.apsb.2021.12.014
   PubMed Web of Science ®Google Scholar
• Kong F, Ye B, Cao J, et al. Curcumin Represses NLRP3 inflammasome activation via TLR4/MyD88/NF-κB and P2X7R Signaling in PMA-induced macrophages. Front Pharmacol. 2016;7:369. doi:10.3389/fphar.2016.00369
   PubMed Web of Science ®Google Scholar
• Yuan Y, Zhang C, He Y, et al. Curcumin improves the function of umbilical vein endothelial cells by inhibiting H2O2-induced pyroptosis. Mol Med Rep. 2022;25(6):214. doi:10.3892/mmr.2022.12730
   PubMed Web of Science ®Google Scholar
• Sun Y, Hu X, Hu G, et al. curcumin attenuates hydrogen peroxide-induced premature senescence via the activation of SIRT1 in human umbilical vein endothelial cells. Biol Pharm Bull. 2015;38(8):1134–1141. doi:10.1248/bpb.b15-00012
   PubMed Web of Science ®Google Scholar
• Chen X, Chen X, Shi X, et al. Curcumin attenuates endothelial cell fibrosis through inhibiting endothelial-interstitial transformation. Clin Exp Pharmacol Physiol. 2020;47(7):1182–1192. doi:10.1111/1440-1681.13271
   PubMed Web of Science ®Google Scholar
• Shao J, Han J, Zhu Y, et al. Curcumin induces endothelium-dependent relaxation by activating endothelial TRPV4 channels. J Cardiovasc Transl Res. 2019;12(6):600–607. doi:10.1007/s12265-019-09928-8
   PubMed Web of Science ®Google Scholar
• Han Y, Sun HJ, Tong Y, et al. Curcumin attenuates migration of vascular smooth muscle cells via inhibiting NFκB-mediated NLRP3 expression in spontaneously hypertensive rats. J Nutr Biochem. 2019;72:108212. doi:10.1016/j.jnutbio.2019.07.003
   PubMed Web of Science ®Google Scholar
• Zhang M, Li Y, Xie H, et al. Curcumin inhibits proliferation, migration and neointimal formation of vascular smooth muscle via activating miR-22. Pharm Biol. 2020;58(1):610–619. doi:10.1080/13880209.2020.1781904
   PubMed Web of Science ®Google Scholar
• He Y, Wang R, Zhang P, et al. Curcumin inhibits the proliferation and migration of vascular smooth muscle cells by targeting the chemerin / CMKLR1 / LCN2 axis. Aging (Albany NY). 2021;13(10):13859–13875. doi:10.18632/aging.202980
   PubMedGoogle Scholar
• Youreva V, Kapakos G, Srivastava AK. Insulin-like growth-factor-1-induced PKB signaling and Egr-1 expression is inhibited by curcumin in A-10 vascular smooth muscle cells. Can J Physiol Pharmacol. 2013;91(3):241–247. doi:10.1139/cjpp-2012-0267
   PubMed Web of Science ®Google Scholar
• Aoyagi M, Yamamoto M, Azuma H, et al. Immunolocalization of matrix metalloproteinases in rabbit carotid arteries after balloon denudation. Histochem Cell Biol. 1998;109(2):97–102. doi:10.1007/s004180050206
   PubMed Web of Science ®Google Scholar
• Zhong Y, Feng J, Li J, Fan Z. Curcumin prevents lipopolysaccharide-induced matrix metalloproteinase-2 activity via the Ras/MEK1/2 signaling pathway in rat vascular smooth muscle cells. Mol Med Rep. 2017;16(4):4315–4319. doi:10.3892/mmr.2017.7037
   PubMed Web of Science ®Google Scholar
• Han Y, Sun HJ, Tong Y, et al. Curcumin attenuates migration of vascular smooth muscle cells via inhibiting NFκB-mediated NLRP3 expression in spontaneously hypertensive rats. J Nutr Biochem. 2019;72:108212.
   PubMed Web of Science ®Google Scholar
• Ansar W, Ghosh S. C-reactive protein and the biology of disease. Immunol Res. 2013;56(1):131–142. doi:10.1007/s12026-013-8384-0
   PubMed Web of Science ®Google Scholar
• Meng Z, Yan C, Deng Q, et al. Curcumin inhibits LPS-induced inflammation in rat vascular smooth muscle cells in vitro via ROS-relative TLR4-MAPK/NF-κB pathways. Acta Pharmacol Sin. 2013;34(7):901–911. doi:10.1038/aps.2013.24
   PubMed Web of Science ®Google Scholar
• Zhong Y, Liu T, Guo Z. Curcumin inhibits ox-LDL-induced MCP-1 expression by suppressing the p38MAPK and NF-κB pathways in rat vascular smooth muscle cells. Inflamm Res. 2012;61(1):61–67. doi:10.1007/s00011-011-0389-3
   PubMed Web of Science ®Google Scholar
• Ruan H, Huang Q, Wan B, et al. Curcumin alleviates lipopolysaccharides-induced inflammation and apoptosis in vascular smooth muscle cells via inhibition of the NF-κB and JNK signaling pathways. Inflammopharmacology. 2022;30(2):517–525. doi:10.1007/s10787-021-00912-w
   PubMed Web of Science ®Google Scholar
• Yao Y, Wang W, Li M, et al. Curcumin exerts its anti-hypertensive effect by down-regulating the AT1 receptor in vascular smooth muscle cells. Sci Rep. 2016;6:25579. doi:10.1038/srep25579
   PubMed Web of Science ®Google Scholar
• Kapakos G, Youreva V, Srivastava AK. Attenuation of endothelin-1-induced PKB and ERK1/2 signaling, as well as Egr-1 expression, by curcumin in A-10 vascular smooth muscle cells. Can J Physiol Pharmacol. 2012;90(9):1277–1285. doi:10.1139/y2012-059
   PubMed Web of Science ®Google Scholar
• Sun SY, Cao YM, Huo YJ, et al. Nicotinate-curcumin inhibits AngII-induced vascular smooth muscle cell phenotype switching by upregulating Daxx expression. Cell Adh Migr. 2021;15(1):116–125. doi:10.1080/19336918.2021.1909899
   PubMed Web of Science ®Google Scholar
• Guzik TJ, Mussa S, Gastaldi D, et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NADPH oxidase and endothelial nitric oxide synthase. Circulation. 2002;105(14):1656–1662. doi:10.1161/01.CIR.0000012748.58444.08
   PubMed Web of Science ®Google Scholar
• Hink U, Li H, Mollnau H, et al. Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ Res. 2001;88(2):E14–22. doi:10.1161/01.RES.88.2.e14
   PubMed Web of Science ®Google Scholar
• Antoniades C, Bakogiannis C, Tousoulis D, et al. The CD40/CD40 ligand system: linking inflammation with atherothrombosis. J Am Coll Cardiol. 2009;54(8):669–677. doi:10.1016/j.jacc.2009.03.076
   PubMed Web of Science ®Google Scholar
• Bhogal RH, Weston CJ, Curbishley SM, et al. Activation of CD40 with platelet derived CD154 promotes reactive oxygen species dependent death of human hepatocytes during hypoxia and reoxygenation. PLoS One. 2012;7(1):e30867. doi:10.1371/journal.pone.0030867
   PubMed Web of Science ®Google Scholar
• Molteni M, Gemma S, Rossetti C. The role of toll-like receptor 4 in infectious and noninfectious inflammation. Mediators Inflamm. 2016;2016:6978936. doi:10.1155/2016/6978936
   PubMed Web of Science ®Google Scholar
• den Dekker WK, Cheng C, Pasterkamp G, et al. Toll like receptor 4 in atherosclerosis and plaque destabilization. Atherosclerosis. 2010;209(2):314–320. doi:10.1016/j.atherosclerosis.2009.09.075
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4(7):499–511. doi:10.1038/nri1391
   PubMed Web of Science ®Google Scholar
• Wang H, Bloom O, Zhang M, et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science. 1999;285(5425):248–51. doi:10.1126/science.285.5425.248
   PubMed Web of Science ®Google Scholar
• Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature. 2004;432(7019):917–21. doi:10.1038/nature03104
   PubMed Web of Science ®Google Scholar
• Lee TS, Chau LY. Heme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice. Nat Med. 2002;8(3):240–246. doi:10.1038/nm0302-240
   PubMed Web of Science ®Google Scholar
• Soares MP, Seldon MP, Gregoire IP, et al. Heme oxygenase-1 modulates the expression of adhesion molecules associated with endothelial cell activation. J Immunol. 2004;172(6):3553–3563. doi:10.4049/jimmunol.172.6.3553
   PubMed Web of Science ®Google Scholar
• Brownlee M, Cerami A, Vlassara H, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318(20):1315–1321. doi:10.1056/NEJM198805193182007
   PubMed Web of Science ®Google Scholar
• van Eupen MG, Schram MT, Colhoun HM, et al. The methylglyoxal-derived AGE tetrahydropyrimidine is increased in plasma of individuals with type 1 diabetes mellitus and in atherosclerotic lesions and is associated with sVCAM-1. Diabetologia. 2013;56(8):1845–1855. doi:10.1007/s00125-013-2919-8
   PubMed Web of Science ®Google Scholar
• Selhub J, D’Angelo A. Relationship between homocysteine and thrombotic disease. Am J Med Sci. 1998;316(2):129–141. doi:10.1097/00000441-199808000-00008
   PubMed Web of Science ®Google Scholar
• Mallick SP, Singh BN, Rastogi A, Srivastava P. Design and evaluation of chitosan/poly(l-lactide)/pectin based composite scaffolds for cartilage tissue regeneration. Int J Biol Macromol. 2018;112:909–920. doi:10.1016/j.ijbiomac.2018.02.049
   PubMed Web of Science ®Google Scholar
• Linton MF, Fazio S. Macrophages, inflammation, and atherosclerosis. Int J Obes Relat Metab Disord. 2003;27:S35–40. doi:10.1038/sj.ijo.0802498
   PubMed Web of Science ®Google Scholar
• Lessner SM, Prado HL, Waller EK, Galis ZS. Atherosclerotic lesions grow through recruitment and proliferation of circulating monocytes in a murine model. Am J Pathol. 2002;160(6):2145–2155. doi:10.1016/S0002-9440(10)61163-7
   PubMed Web of Science ®Google Scholar
• Weber C, Schober A, Zernecke A. Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease. Arterioscler Thromb Vasc Biol. 2004;24(11):1997–2008. doi:10.1161/01.ATV.0000142812.03840.6f
   PubMed Web of Science ®Google Scholar
• Xu X, Gao X, Potter BJ, et al. Anti-LOX-1 rescues endothelial function in coronary arterioles in atherosclerotic ApoE knockout mice. Arterioscler Thromb Vasc Biol. 2007;27(4):871–877. doi:10.1161/01.ATV.0000259358.31234.37
   PubMed Web of Science ®Google Scholar
• Stewart BW, Nagarajan S. Recombinant CD36 inhibits ox-LDL-induced ICAM-1-dependent monocyte adhesion. Mol Immunol. 2006;43(3):255–267. doi:10.1016/j.molimm.2005.02.007
   PubMed Web of Science ®Google Scholar
• Stewart FA, Hoving S, Russell NS. Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients. Radiat Res. 2010;174(6):865–869. doi:10.1667/RR1862.1
   PubMed Web of Science ®Google Scholar
• Poznyak A, Grechko AV, Poggio P, et al. The diabetes mellitus-atherosclerosis connection: the role of lipid and glucose metabolism and chronic inflammation. Int J Mol Sci. 2020;21(5):1835. doi:10.3390/ijms21051835
   PubMed Web of Science ®Google Scholar
• Hasan ST, Zingg JM, Kwan P, Noble T, Smith D, Meydani M. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice. Atherosclerosis. 2014;232(1):40–51. doi:10.1016/j.atherosclerosis.2013.10.016
   PubMed Web of Science ®Google Scholar
• Um MY, Hwang KH, Choi WH, et al. Curcumin attenuates adhesion molecules and matrix metalloproteinase expression in hypercholesterolemic rabbits. Nutr Res. 2014;34(10):886–893. doi:10.1016/j.nutres.2014.09.001
   PubMed Web of Science ®Google Scholar
• Innerarity TL, Mahley RW. Enhanced binding by cultured human fibroblasts of apo-E-containing lipoproteins as compared with low density lipoproteins. Biochemistry. 1978;17(8):1440–1447. doi:10.1021/bi00601a013
   PubMed Web of Science ®Google Scholar
• Petroianu A, Veloso DF, Costa GR, Alberti LR. Effects of splenic surgeries on lipidogram of rats. Rev Assoc Med Bras. 2006;52(1):56–59. doi:10.1590/S0104-42302006000100024
   PubMedGoogle Scholar
• Gonçalves TB, Yamaki VN, Feijó DH, et al. Effects of splenic allograft in lipid profile of non-splenectomized rats: the immune and metabolic role of the ”double spleen”. Rev Col Bras Cir. 2014;41(2):122–127. English, Portuguese. doi:10.1590/S0100-69912014000200009
   PubMedGoogle Scholar
• Lusis AJ. Atherosclerosis. Nature. 2000;407(6801):233–41. doi:10.1038/35025203
   PubMed Web of Science ®Google Scholar
• Kleemann R, Zadelaar S, Kooistra T. Cytokines and atherosclerosis: a comprehensive review of studies in mice. Cardiovasc Res. 2008;79(3):360–376. doi:10.1093/cvr/cvn120
   PubMed Web of Science ®Google Scholar
• Collot-Teixeira S, Martin J, McDermott-Roe C, et al. CD36 and macrophages in atherosclerosis. Cardiovasc Res. 2007;75(3):468–477. doi:10.1016/j.cardiores.2007.03.010
   PubMed Web of Science ®Google Scholar
• Kunjathoor VV, Febbraio M, Podrez EA, et al. Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem. 2002;277(51):49982–49988. doi:10.1074/jbc.M209649200
   PubMed Web of Science ®Google Scholar
• Cheng LC, Su KH, Kou YR, et al. α-Lipoic acid ameliorates foam cell formation via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1. Free Radic Biol Med. 2011;50(1):47–54. doi:10.1016/j.freeradbiomed.2010.10.706
   PubMed Web of Science ®Google Scholar
• Ji A, Meyer JM, Cai L, et al. Scavenger receptor SR-BI in macrophage lipid metabolism. Atherosclerosis. 2011;217(1):106–112. doi:10.1016/j.atherosclerosis.2011.03.017
   PubMed Web of Science ®Google Scholar
• Bonamassa B, Moschetta A. Atherosclerosis: lessons from LXR and the intestine. Trends Endocrinol Metab. 2013;24(3):120–128. doi:10.1016/j.tem.2012.10.004
   PubMed Web of Science ®Google Scholar
• Chen FY, Zhou J, Guo N, et al. Curcumin retunes cholesterol transport homeostasis and inflammation response in M1 macrophage to prevent atherosclerosis. Biochem Biophys Res Commun. 2015;467(4):872–878. doi:10.1016/j.bbrc.2015.10.051
   PubMed Web of Science ®Google Scholar
• Zingg JM, Hasan ST, Nakagawa K, et al. Modulation of cAMP levels by high-fat diet and curcumin and regulatory effects on CD36/FAT scavenger receptor/fatty acids transporter gene expression. Biofactors. 2017;43(1):42–53.
   PubMed Web of Science ®Google Scholar
• Laskin DL. Macrophages and inflammatory mediators in chemical toxicity: a battle of forces. Chem Res Toxicol. 2009;22(8):1376–1385. doi:10.1021/tx900086v
   PubMed Web of Science ®Google Scholar
• Fagerberg B, Barregard L, Sallsten G, et al. Cadmium exposure and atherosclerotic carotid plaques--results from the Malmö diet and Cancer study. Environ Res. 2015;136:67–74. doi:10.1016/j.envres.2014.11.004
   PubMed Web of Science ®Google Scholar
• Fuster V, Kovacic JC. Acute coronary syndromes: pathology, diagnosis, genetics, prevention, and treatment. Circ Res. 2014;114(12):1847–1851. doi:10.1161/CIRCRESAHA.114.302806
   PubMed Web of Science ®Google Scholar
• Forslöw A, Liu Z, Sundqvist KG. Receptor communication within the lymphocyte plasma membrane: a role for the thrombospondin family of matricellular proteins. Cell Mol Life Sci. 2007;64(1):66–76. doi:10.1007/s00018-006-6255-8
   PubMed Web of Science ®Google Scholar
• Elavarasu S, Suthanthiran T, Thangavelu A, et al. Evaluation of superoxide dismutase levels in local drug delivery system containing 0.2% curcumin strip as an adjunct to scaling and root planing in chronic periodontitis: a clinical and biochemical study. J Pharm Bioallied Sci. 2016;8(Suppl 1):48. doi:10.4103/0975-7406.191967
   Google Scholar
• Hosseini A, Rasmi Y, Rahbarghazi R, et al. Curcumin modulates the angiogenic potential of human endothelial cells via FAK/P-38 MAPK signaling pathway. Gene. 2019;688:7–12. doi:10.1016/j.gene.2018.11.062
   PubMed Web of Science ®Google Scholar
• Textor SC, Taler SJ, Canzanello VJ, Schwartz L, Augustine JE. Posttransplantation hypertension related to calcineurin inhibitors. Liver Transpl. 2000;6(5):521–530. doi:10.1053/jlts.2000.9737
   PubMed Web of Science ®Google Scholar
• Soultati A, Mountzios G, Avgerinou C, et al. Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications. Cancer Treat Rev. 2012;38(5):473–483. doi:10.1016/j.ctrv.2011.09.002
   PubMed Web of Science ®Google Scholar
• Liu HT, Li F, Wang WY, et al. Rapamycin inhibits re-endothelialization after percutaneous coronary intervention by impeding the proliferation and migration of endothelial cells and inducing apoptosis of endothelial progenitor cells. Tex Heart Inst J. 2010;37(2):194–201.
   PubMed Web of Science ®Google Scholar
• Verdoia M, Kedhi E, Suryapranata H, et al. Poly (l -lactic acid) bioresorbable scaffolds versus metallic drug-eluting stents for the treatment of coronary artery disease: a meta-analysis of 11 randomized trials. Catheter Cardiovasc Interv. 2020;96(4):813–824. doi:10.1002/ccd.28594
   PubMed Web of Science ®Google Scholar
• Kataoka H, Kume N, Miyamoto S, et al. Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation. 1999;99(24):3110–3117. doi:10.1161/01.CIR.99.24.3110
   PubMed Web of Science ®Google Scholar
• Xu HS, Duan J, Dai S, et al. Phytoestrogen alpha-zearalanol antagonizes oxidized LDL-induced inhibition of nitric oxide production and stimulation of endothelin-1 release in human umbilical vein endothelial cells. Endocrine. 2004;25(3):235–245. doi:10.1385/ENDO:25:3:235
   PubMed Web of Science ®Google Scholar
• Ye M, Qiu H, Cao Y, et al. Curcumin improves palmitate-induced insulin resistance in human umbilical vein endothelial cells by maintaining proteostasis in endoplasmic reticulum. Front Pharmacol. 2017;8:148. doi:10.3389/fphar.2017.00148
   PubMed Web of Science ®Google Scholar
• Sreejayan Rao MN, Rao MNA. Nitric oxide scavenging by curcuminoids. J Pharm Pharmacol. 1997;49(1):105–107. doi:10.1111/j.2042-7158.1997.tb06761.x
   PubMed Web of Science ®Google Scholar
• Latz E, Xiao TS, Stutz A. Activation and regulation of the inflammasomes. Nat Rev Immunol. 2013;13(6):397–411. doi:10.1038/nri3452
   PubMed Web of Science ®Google Scholar
• Miao EA, Leaf IA, Treuting PM, et al. Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria. Nat Immunol. 2010;11(12):1136–1142. doi:10.1038/ni.1960
   PubMed Web of Science ®Google Scholar
• Campisi J, d’Adda Di Fagagna F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8(9):729–740. doi:10.1038/nrm2233
   PubMed Web of Science ®Google Scholar
• Ota H, Akishita M, Eto M, et al. Sirt1 modulates premature senescence-like phenotype in human endothelial cells. J Mol Cell Cardiol. 2007;43(5):571–579. doi:10.1016/j.yjmcc.2007.08.008
   PubMed Web of Science ®Google Scholar
• Zeisberg EM, Tarnavski O, Zeisberg M, et al. Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nat Med. 2007;13(8):952–961. doi:10.1038/nm1613
   PubMed Web of Science ®Google Scholar
• Xiang Y, Zhang Y, Tang Y, Li Q. MALAT1 modulates TGF-β1-induced endothelial-to-mesenchymal transition through downregulation of miR-145. Cell Physiol Biochem. 2017;42(1):357–372. doi:10.1159/000477479
   PubMedGoogle Scholar
• Peixoto-Neves D, Wang Q, Leal-Cardoso JH, et al. Eugenol dilates mesenteric arteries and reduces systemic BP by activating endothelial cell TRPV 4 channels. Br J Pharmacol. 2015;172(14):3484–3494. doi:10.1111/bph.13156
   PubMed Web of Science ®Google Scholar
• Bubolz AH, Mendoza SA, Zheng X, et al. Activation of endothelial TRPV4 channels mediates flow-induced dilation in human coronary arterioles: role of Ca 2+ entry and mitochondrial ROS signaling. Am J Physiol Heart Circ Physiol. 2012;302(3):H634–H642. doi:10.1152/ajpheart.00717.2011
   PubMed Web of Science ®Google Scholar
• Willis AI, Pierre-Paul D, Sumpio BE, et al. Vascular smooth muscle cell migration: current research and clinical implications. Vasc Endovascular Surg. 2004;38(1):11–23. doi:10.1177/153857440403800102
   PubMedGoogle Scholar
• Zylla S, Dörr M, Völzke H, et al. Association of circulating chemerin with subclinical parameters of atherosclerosis: results of a population-based study. Arterioscler Thromb Vasc Biol. 2018;38(7):1656–1664. doi:10.1161/ATVBAHA.118.311219
   PubMed Web of Science ®Google Scholar
• Meng D, Shi X, Jiang BH, et al. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Free Radic Biol Med. 2007;42(11):1651–1660. doi:10.1016/j.freeradbiomed.2007.01.037
   PubMed Web of Science ®Google Scholar
• Chistiakov DA, Orekhov AN, Bobryshev YV. Vascular smooth muscle cell in atherosclerosis. Acta Physiol. 2015;214(1):33–50. doi:10.1111/apha.12466
   PubMed Web of Science ®Google Scholar
• Moon JY. Recent update of renin-angiotensin-aldosterone system in the pathogenesis of hypertension. Electrolyte Blood Press. 2013;11(2):41–45. doi:10.5049/EBP.2013.11.2.41
   PubMedGoogle Scholar
• Choi Y, Tanabe Y, Akazawa N, et al. Curcumin supplementation attenuates the decrease in endothelial function following eccentric exercise. J Exerc Nutrition Biochem. 2019;23(2):7–12. doi:10.20463/jenb.2019.0010
   PubMedGoogle Scholar
• Oliver JM, Stoner L, Rowlands DS, et al. Novel form of curcumin improves endothelial function in young, healthy individuals: a double-blind placebo controlled study. J Nutr Metab. 2016;2016:1089653. doi:10.1155/2016/1089653
   PubMed Web of Science ®Google Scholar
• Hallajzadeh J, Milajerdi A, Kolahdooz F, et al. The effects of curcumin supplementation on endothelial function: a systematic review and meta-analysis of randomized controlled trials. Phytother Res. 2019;33(11):2989–2995. doi:10.1002/ptr.6477
   PubMed Web of Science ®Google Scholar
• Santos-Parker JR, Strahler TR, Bassett CJ, et al. Curcumin supplementation improves vascular endothelial function in healthy middle-aged and older adults by increasing nitric oxide bioavailability and reducing oxidative stress. Aging. 2017;9(1):187–208. doi:10.18632/aging.101149
   PubMedGoogle Scholar
• Xu Y, Nie L, Yin YG, et al. Resveratrol protects against hyperglycemia-induced oxidative damage to mitochondria by activating SIRT1 in rat mesangial cells. Toxicol Appl Pharmacol. 2012;259(3):395–401. doi:10.1016/j.taap.2011.09.028
   PubMed Web of Science ®Google Scholar
• Yang Y, Duan W, Lin Y, et al. SIRT1 activation by curcumin pretreatment attenuates mitochondrial oxidative damage induced by myocardial ischemia reperfusion injury. Free Radic Biol Med. 2013;65:667–679. doi:10.1016/j.freeradbiomed.2013.07.007
   PubMed Web of Science ®Google Scholar
• Barry SP, Townsend PA, Latchman DS, et al. Role of the JAK-STAT pathway in myocardial injury. Trends Mol Med. 2007;13(2):82–89. doi:10.1016/j.molmed.2006.12.002
   PubMed Web of Science ®Google Scholar
• Duan W, Yang Y, Yan J, et al. The effects of curcumin post-treatment against myocardial ischemia and reperfusion by activation of the JAK2/STAT3 signaling pathway. Basic Res Cardiol. 2012;107(3):263. doi:10.1007/s00395-012-0263-7
   PubMed Web of Science ®Google Scholar
• Liu H, Wang C, Qiao Z, Xu Y. Protective effect of curcumin against myocardium injury in ischemia reperfusion rats. Pharm Biol. 2017;55(1):1144–1148. doi:10.1080/13880209.2016.1214741
   PubMed Web of Science ®Google Scholar
• van den Berg TK, Yoder JA, Litman GW. On the origins of adaptive immunity: innate immune receptors join the tale. Trends Immunol. 2004;25(1):11–16. doi:10.1016/j.it.2003.11.006
   PubMed Web of Science ®Google Scholar
• Kim YS, Kwon JS, Cho YK, et al. Curcumin reduces the cardiac ischemia-reperfusion injury: involvement of the toll-like receptor 2 in cardiomyocytes. J Nutr Biochem. 2012;23(11):1514–1523. doi:10.1016/j.jnutbio.2011.10.004
   PubMed Web of Science ®Google Scholar
• Fiorillo C, Becatti M, Pensalfini A, et al. Curcumin protects cardiac cells against ischemia-reperfusion injury: effects on oxidative stress, NF-kappaB, and JNK pathways. Free Radic Biol Med. 2008;45(6):839–846. doi:10.1016/j.freeradbiomed.2008.06.013
   PubMed Web of Science ®Google Scholar
• Zhu P, Yang M, He H, et al. Curcumin attenuates hypoxia/reoxygenation-induced cardiomyocyte injury by downregulating Notch signaling. Mol Med Rep. 2019;20(2):1541–1550. doi:10.3892/mmr.2019.10371
   PubMed Web of Science ®Google Scholar
• Cui JK, Wang X, Fan M, et al. Curcuminoids attenuate myocardial ischemia-reperfusion injury by regulating total RNA M6a levels: in vitro study. Comb Chem High Throughput Screen. 2023;26(10):1848–1855. doi:10.2174/1386207325666220929141003
   PubMed Web of Science ®Google Scholar
• Izem-Meziane M, Djerdjouri B, Rimbaud S, et al. Catecholamine-induced cardiac mitochondrial dysfunction and mPTP opening: protective effect of curcumin. Am J Physiol Heart Circ Physiol. 2012;302(3):H665–H674. doi:10.1152/ajpheart.00467.2011
   PubMed Web of Science ®Google Scholar
• Tanwar V, Sachdeva J, Golechha M, et al. Curcumin protects rat myocardium against isoproterenol-induced ischemic injury: attenuation of ventricular dysfunction through increased expression of Hsp27 along with strengthening antioxidant defense system. J Cardiovasc Pharmacol. 2010;55(4):377–384. doi:10.1097/FJC.0b013e3181d3da01
   PubMed Web of Science ®Google Scholar
• Geng HH, Li R, Su YM, et al. Curcumin protects cardiac myocyte against hypoxia-induced apoptosis through upregulating miR-7a/b expression. Biomed Pharmacother. 2016;81:258–264. doi:10.1016/j.biopha.2016.04.020
   PubMed Web of Science ®Google Scholar
• Liu Y, Liu Y, Huang X, et al. Protective effects and mechanism of curcumin on myocardial injury induced by coronary microembolization. J Cell Biochem. 2019;120(4):5695–5703. doi:10.1002/jcb.27854
   PubMed Web of Science ®Google Scholar
• Moulin S, Arnaud C, Bouyon S, et al. Curcumin prevents chronic intermittent hypoxia-induced myocardial injury. Ther Adv Chronic Dis. 2020;11:2040622320922104. doi:10.1177/2040622320922104
   Web of Science ®Google Scholar
• Sunagawa Y, Funamoto M, Sono S, et al. Curcumin and its demethoxy derivatives possess p300 HAT inhibitory activity and suppress hypertrophic responses in cardiomyocytes. J Pharmacol Sci. 2018;136(4):212–217. doi:10.1016/j.jphs.2017.12.013
   PubMed Web of Science ®Google Scholar
• Sunagawa Y, Funamoto M, Shimizu K, et al. Curcumin, an inhibitor of p300-HAT activity, suppresses the development of hypertension-induced left ventricular hypertrophy with preserved ejection fraction in dahl rats. Nutrients. 2021;13(8):2608. doi:10.3390/nu13082608
   PubMed Web of Science ®Google Scholar
• Chowdhury R, Nimmanapalli R, Graham T, et al. Curcumin attenuation of lipopolysaccharide induced cardiac hypertrophy in rodents. ISRN Inflamm. 2013;2013:539305. doi:10.1155/2013/539305
   PubMedGoogle Scholar
• Ahuja S, Kohli S, Krishnan S, et al. Curcumin: a potential therapeutic polyphenol, prevents noradrenaline-induced hypertrophy in rat cardiac myocytes. J Pharm Pharmacol. 2011;63(12):1604–1612. doi:10.1111/j.2042-7158.2011.01363.x
   PubMed Web of Science ®Google Scholar
• Bai XJ, Hao JT, Wang J, et al. Curcumin inhibits cardiac hypertrophy and improves cardiovascular function via enhanced Na+/Ca2+ exchanger expression after transverse abdominal aortic constriction in rats. Pharmacol Rep. 2018;70(1):60–68. doi:10.1016/j.pharep.2017.07.014
   PubMed Web of Science ®Google Scholar
• Ghosh SS, Salloum FN, Abbate A, et al. Curcumin prevents cardiac remodeling secondary to chronic renal failure through deactivation of hypertrophic signaling in rats. Am J Physiol Heart Circ Physiol. 2010;299(4):H975–H984. doi:10.1152/ajpheart.00154.2010
   PubMed Web of Science ®Google Scholar
• Fang G, Chen S, Huang Q, et al. Curcumin suppresses cardiac fibroblasts activities by regulating the proliferation and cell cycle via the inhibition of the p38 MAPK/ERK signaling pathway. Mol Med Rep. 2018;18(2):1433–1438. doi:10.3892/mmr.2018.9120
   PubMed Web of Science ®Google Scholar
• Liu H, Liu A, Shi C, et al. Curcumin suppresses transforming growth factor-β1-induced cardiac fibroblast differentiation via inhibition of Smad-2 and p38 MAPK signaling pathways. Exp Ther Med. 2016;11(3):998–1004. doi:10.3892/etm.2016.2969
   PubMed Web of Science ®Google Scholar
• Meng Z, Yu XH, Chen J, et al. Curcumin attenuates cardiac fibrosis in spontaneously hypertensive rats through PPAR-γ activation. Acta Pharmacol Sin. 2014;35(10):1247–1256. doi:10.1038/aps.2014.63
   PubMed Web of Science ®Google Scholar
• Ma J, Ma SY, Ding CH. Curcumin reduces cardiac fibrosis by inhibiting myofibroblast differentiation and decreasing transforming growth factor β1 and matrix metalloproteinase 9 / tissue inhibitor of metalloproteinase 1. Chin J Integr Med. 2017;23(5):362–369. doi:10.1007/s11655-015-2159-5
   PubMed Web of Science ®Google Scholar
• Pang XF, Zhang LH, Bai F, et al. Attenuation of myocardial fibrosis with curcumin is mediated by modulating expression of angiotensin II AT1/AT2 receptors and ACE2 in rats. Drug Des Devel Ther. 2015;9:6043–6054. doi:10.2147/DDDT.S95333
   PubMed Web of Science ®Google Scholar
• Guo S, Meng XW, Yang XS, et al. Curcumin administration suppresses collagen synthesis in the hearts of rats with experimental diabetes. Acta Pharmacol Sin. 2018;39(2):195–204. doi:10.1038/aps.2017.92
   PubMed Web of Science ®Google Scholar
• Wang NP, Wang ZF, Tootle S, et al. Curcumin promotes cardiac repair and ameliorates cardiac dysfunction following myocardial infarction. Br J Pharmacol. 2012;167(7):1550–1562. doi:10.1111/j.1476-5381.2012.02109.x
   PubMed Web of Science ®Google Scholar
• Xiao J, Sheng X, Zhang X, et al. Curcumin protects against myocardial infarction-induced cardiac fibrosis via SIRT1 activation in vivo and in vitro. Drug Des Devel Ther. 2016;10:1267–1277. doi:10.2147/DDDT.S104925
   PubMed Web of Science ®Google Scholar
• Boarescu PM, Chirilă I, Bulboacă AE, et al. Effects of curcumin nanoparticles in isoproterenol-induced myocardial infarction. Oxid Med Cell Longev. 2019;2019:7847142. doi:10.1155/2019/7847142
   PubMed Web of Science ®Google Scholar
• Kohli S, Chhabra A, Jaiswal A, et al. Curcumin suppresses gelatinase B mediated norepinephrine induced stress in H9c2 cardiomyocytes. PLoS One. 2013;8(10):e76519. doi:10.1371/journal.pone.0076519
   PubMed Web of Science ®Google Scholar
• Rice KM, Manne ND, Kolli MB, et al. Curcumin nanoparticles attenuate cardiac remodeling due to pulmonary arterial hypertension. Artif Cells Nanomed Biotechnol. 2016;44(8):1909–1916. doi:10.3109/21691401.2015.1111235
   PubMed Web of Science ®Google Scholar
• Cao Q, Zhang J, Gao L, et al. Dickkopf-3 upregulation mediates the cardioprotective effects of curcumin on chronic heart failure. Mol Med Rep. 2018;17(5):7249–7257. doi:10.3892/mmr.2018.8783
   PubMed Web of Science ®Google Scholar
• Mito S, Thandavarayan RA, Ma M, et al. Inhibition of cardiac oxidative and ERS-mediated apoptosis by curcumin treatment contributes to protection against acute myocarditis. Free Radic Res. 2011;45(10):1223–1231. doi:10.3109/10715762.2011.607252
   PubMed Web of Science ®Google Scholar
• Gao S, Zhou J, Liu N, et al. Curcumin induces M2 macrophage polarization by secretion IL-4 and/or IL-13. J Mol Cell Cardiol. 2015;85:131–139. doi:10.1016/j.yjmcc.2015.04.025
   PubMed Web of Science ®Google Scholar
• Ren BC, Zhang YF, Liu SS, et al. Curcumin alleviates oxidative stress and inhibits apoptosis in diabetic cardiomyopathy via Sirt1-Foxo1 and PI3K-Akt signalling pathways. J Cell Mol Med. 2020;24(21):12355–12367. doi:10.1111/jcmm.15725
   PubMed Web of Science ®Google Scholar
• Yu W, Wu J, Cai F, et al. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS One. 2012;7(12):e52013. doi:10.1371/journal.pone.0052013
   PubMed Web of Science ®Google Scholar
• Abdelsamia EM, Khaleel SA, Balah A, et al. Curcumin augments the cardioprotective effect of metformin in an experimental model of type I diabetes mellitus; Impact of Nrf2/HO-1 and JAK/STAT pathways. Biomed Pharmacother. 2019;109:2136–2144. doi:10.1016/j.biopha.2018.11.064
   PubMed Web of Science ®Google Scholar
• Aziz MT, El Ibrashy IN, Mikhailidis DP, et al. Signaling mechanisms of a water soluble curcumin derivative in experimental type 1 diabetes with cardiomyopathy. Diabetol Metab Syndr. 2013;5(1):13. doi:10.1186/1758-5996-5-13
   PubMedGoogle Scholar
• Gbr AA, Abdel Baky NA, Mohamed EA, et al. Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII/NF-κB/TGF-β1 and PPAR-γ signaling pathway. Naunyn Schmiedebergs Arch Pharmacol. 2021;394(2):349–360. doi:10.1007/s00210-020-01979-y
   PubMed Web of Science ®Google Scholar
• Yan X, Xu P, Zhou L, et al. Blockade of high mobility group box 1 involved in the protective of curcumin on myocardial injury in diabetes in vivo and in vitro. IUBMB Life. 2020;72(5):931–941. doi:10.1002/iub.2226
   PubMed Web of Science ®Google Scholar
• Yao Q, Ke ZQ, Guo S, et al. Curcumin protects against diabetic cardiomyopathy by promoting autophagy and alleviating apoptosis. J Mol Cell Cardiol. 2018;124:26–34. doi:10.1016/j.yjmcc.2018.10.004
   PubMed Web of Science ®Google Scholar
• Soliman NA, Abo El Gheit RE, Abdel Ghafar MT, et al. Unraveling the biomechanistic role of Rac1/TWEAK/Fn14/NF-κB intricate network in experimentally doxorubicin-induced cardiotoxicity in rats: the role of curcumin. J Biochem Mol Toxicol. 2021;35(8):e22829. doi:10.1002/jbt.22829
   PubMed Web of Science ®Google Scholar
• He H, Luo Y, Qiao Y, et al. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ. Food Funct. 2018;9(8):4404–4418. doi:10.1039/C8FO00466H
   PubMed Web of Science ®Google Scholar
• Yang L, Shi J, Wang X, et al. Curcumin alleviates D-galactose-induced cardiomyocyte senescence by promoting autophagy via the SIRT1/AMPK/mTOR pathway. Evid Based Complement Alternat Med. 2022;2022:2990843. doi:10.1155/2022/2990843
   PubMed Web of Science ®Google Scholar
• Ghorbanzadeh V, Pourheydar B, Dariushnejad H, et al. Curcumin improves angiogenesis in the heart of aged rats: involvement of TSP1/NF-κB/VEGF-A signaling. Microvasc Res. 2022;139:104258. doi:10.1016/j.mvr.2021.104258
   PubMed Web of Science ®Google Scholar
• El Tabaa MM, Habib EI, Zahran A, et al. SERCA2a directs the cardioprotective role of nano-emulsion curcumin against PM2.5-induced cardiac injury in rats by prohibiting PERK-eIF2α pathway. Life Sci. 2022;311(Pt B):121160. doi:10.1016/j.lfs.2022.121160
   PubMedGoogle Scholar
• Boarescu PM, Boarescu I, Bocșan IC, et al. Curcumin nanoparticles protect against isoproterenol induced myocardial infarction by alleviating myocardial tissue oxidative stress, electrocardiogram, and biological changes. Molecules. 2019;24(15):2802. doi:10.3390/molecules24152802
   PubMed Web of Science ®Google Scholar
• Tan NY, Khachigian LM. Sp1 phosphorylation and its regulation of gene transcription. Mol Cell Biol. 2009;29(10):2483–2488. doi:10.1128/MCB.01828-08
   PubMed Web of Science ®Google Scholar
• Frey N, Katus HA, Olson EN, Hill JA. Hypertrophy of the heart: a new therapeutic target? Circulation. 2004;109(13):1580–1589. doi:10.1161/01.CIR.0000120390.68287.BB
   PubMed Web of Science ®Google Scholar
• Morin S, Paradis P, Aries A, et al. Serum response factor-GATA ternary complex required for nuclear signaling by a G-protein-coupled receptor. Mol Cell Biol. 2001;21(4):1036–1044. doi:10.1128/MCB.21.4.1036-1044.2001
   PubMed Web of Science ®Google Scholar
• Sipido KR, Volders PG, Vos MA, Verdonck F. Altered Na/Ca exchange activity in cardiac hypertrophy and heart failure: a new target for therapy? Cardiovasc Res. 2002;53(4):782–805. doi:10.1016/S0008-6363(01)00470-9
   PubMed Web of Science ®Google Scholar
• Wang J, Song Y, Wang Q, et al. Causes and characteristics of diabetic cardiomyopathy. Rev Diabet Stud. 2006;3(3):108–117. doi:10.1900/RDS.2006.3.108
   PubMedGoogle Scholar
• Sudirman S, Lai CS, Yan YL, et al. Histological evidence of chitosan-encapsulated curcumin suppresses heart and kidney damages on streptozotocin-induced type-1 diabetes in mice model. Sci Rep. 2019;9(1):15233. doi:10.1038/s41598-019-51821-6
   PubMedGoogle Scholar
• Kong P, Christia P, Frangogiannis NG. The pathogenesis of cardiac fibrosis. Cell Mol Life Sci. 2014;71(4):549–574. doi:10.1007/s00018-013-1349-6
   PubMed Web of Science ®Google Scholar
• Krenning G, Zeisberg EM, Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol. 2010;225(3):631–637. doi:10.1002/jcp.22322
   PubMed Web of Science ®Google Scholar
• Ivey MJ, Tallquist MD. Defining the Cardiac Fibroblast. Circ J. 2016;80(11):2269–2276. doi:10.1253/circj.CJ-16-1003
   PubMed Web of Science ®Google Scholar
• Zhao J, Chen Y, Chen Q, et al. Curcumin ameliorates cardiac fibrosis by regulating macrophage-fibroblast crosstalk via IL18-P-SMAD2/3 signaling pathway inhibition. Front Pharmacol. 2022;12:784041. doi:10.3389/fphar.2021.784041
   PubMed Web of Science ®Google Scholar
• Crowley MJ, Powers BJ, Myers ER, et al. Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treatment of ischemic heart disease: future research needs prioritization. Am Heart J. 2012;163(5):777–782.e8. doi:10.1016/j.ahj.2012.02.016
   PubMed Web of Science ®Google Scholar
• Travers JG, Kamal FA, Robbins J, Yutzey KE, Blaxall BC. Cardiac fibrosis: the fibroblast awakens. Circ Res. 2016;118(6):1021–1040. doi:10.1161/CIRCRESAHA.115.306565
   PubMed Web of Science ®Google Scholar
• Spinale FG, Gunasinghe H, Sprunger PD, et al. Extracellular degradative pathways in myocardial remodeling and progression to heart failure. J Card Fail. 2002;8(6 Suppl):S332–8. doi:10.1054/jcaf.2002.129259
   PubMed Web of Science ®Google Scholar
• Schelbert EB, Piehler KM, Zareba KM, et al. Myocardial Fibrosis quantified by extracellular volume is associated with subsequent hospitalization for heart failure, death, or both across the spectrum of ejection fraction and heart failure stage. J Am Heart Assoc. 2015;4(12):e002613. doi:10.1161/JAHA.115.002613
   PubMed Web of Science ®Google Scholar
• Reinhardt D, Sigusch HH, Hensse J, et al. Cardiac remodelling in end stage heart failure: upregulation of matrix metalloproteinase (MMP) irrespective of the underlying disease, and evidence for a direct inhibitory effect of ACE inhibitors on MMP. Heart. 2002;88(5):525–530. doi:10.1136/heart.88.5.525
   PubMed Web of Science ®Google Scholar
• Hernández-Reséndiz S, Correa F, García-Niño WR, et al. Cardioprotection by curcumin post-treatment in rats with established chronic kidney disease. Cardiovasc Drugs Ther. 2015;29(2):111–120. doi:10.1007/s10557-015-6581-x
   PubMed Web of Science ®Google Scholar
• Ochiai K, Watanabe M, Ueki H, et al. Tumor suppressor REIC/Dkk-3 interacts with the dynein light chain, Tctex-1. Biochem Biophys Res Commun. 2011;412(2):391–395. doi:10.1016/j.bbrc.2011.07.109
   PubMed Web of Science ®Google Scholar
• Zhang Y, Liu Y, Zhu XH, et al. Dickkopf-3 attenuates pressure overload-induced cardiac remodelling. Cardiovasc Res. 2014;102(1):35–45. doi:10.1093/cvr/cvu004
   PubMed Web of Science ®Google Scholar
• Nimata M, Okabe TA, Hattori M, et al. MCI-186 (edaravone), a novel free radical scavenger, protects against acute autoimmune myocarditis in rats. Am J Physiol Heart Circ Physiol. 2005;289(6):H2514–H2518. doi:10.1152/ajpheart.00661.2005
   PubMed Web of Science ®Google Scholar
• Mito S, Watanabe K, Harima M, et al. Curcumin ameliorates cardiac inflammation in rats with autoimmune myocarditis. Biol Pharm Bull. 2011;34(7):974–979. doi:10.1248/bpb.34.974
   PubMed Web of Science ®Google Scholar
• Lee C, Joseph L, Colosimo A, et al. Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis. Diabetes Metab. 2012;38(5):420–427. doi:10.1016/j.diabet.2012.04.002
   PubMed Web of Science ®Google Scholar
• Kuethe F, Sigusch HH, Bornstein SR, et al. Apoptosis in patients with dilated cardiomyopathy and diabetes: a feature of diabetic cardiomyopathy? Horm Metab Res. 2007;39(9):672–676. doi:10.1055/s-2007-985823
   PubMed Web of Science ®Google Scholar
• Liu HJ, Liao HH, Yang Z, et al. Peroxisome proliferator-activated receptor- γ is critical to cardiac fibrosis. PPAR Res. 2016;2016:2198645. doi:10.1155/2016/2198645
   PubMed Web of Science ®Google Scholar
• Zhu H, He L. Beclin 1 biology and its role in heart disease. Curr Cardiol Rev. 2015;11(3):229–237. doi:10.2174/1573403X10666141106104606
   PubMed Web of Science ®Google Scholar
• Deavall DG, Martin EA, Horner JM, et al. Drug-induced oxidative stress and toxicity. J Toxicol. 2012;2012:645460. doi:10.1155/2012/645460
   PubMedGoogle Scholar
• Damiani RM, Moura DJ, Viau CM, et al. Pathways of cardiac toxicity: comparison between chemotherapeutic drugs doxorubicin and mitoxantrone. Arch Toxicol. 2016;90(9):2063–2076. doi:10.1007/s00204-016-1759-y
   PubMed Web of Science ®Google Scholar
• Swamy AV, Gulliaya S, Thippeswamy A, et al. Cardioprotective effect of curcumin against doxorubicin-induced myocardial toxicity in albino rats. Indian J Pharmacol. 2012;44(1):73–77. doi:10.4103/0253-7613.91871
   PubMed Web of Science ®Google Scholar
• van Laar M, Feltbower RG, Gale CP, et al. Cardiovascular sequelae in long-term survivors of young peoples’ cancer: a linked cohort study. Br J Cancer. 2014;110(5):1338–1341. doi:10.1038/bjc.2014.37
   PubMed Web of Science ®Google Scholar
• Bahadır A, Ceyhan A, Öz Gergin Ö, et al. Protective effects of curcumin and beta-carotene on cisplatin-induced cardiotoxicity: an experimental rat model. Anatol J Cardiol. 2018;19(3):213–221. doi:10.14744/AnatolJCardiol.2018.53059
   PubMed Web of Science ®Google Scholar
• Khadrawy YA, Hosny EN, El-Gizawy MM, et al. The effect of curcumin nanoparticles on cisplatin-induced cardiotoxicity in male wistar albino rats. Cardiovasc Toxicol. 2021;21(6):433–443. doi:10.1007/s12012-021-09636-3
   PubMed Web of Science ®Google Scholar
• Bjelogrlic SK, Radic J, Jovic V, et al. Activity of d,l-alpha-tocopherol (vitamin E) against cardiotoxicity induced by doxorubicin and doxorubicin with cyclophosphamide in mice. Basic Clin Pharmacol Toxicol. 2005;97(5):311–319. doi:10.1111/j.1742-7843.2005.pto_166.x
   PubMed Web of Science ®Google Scholar
• Avci H, Epikmen ET, Ipek E, et al. Protective effects of silymarin and curcumin on cyclophosphamide-induced cardiotoxicity. Exp Toxicol Pathol. 2017;69(5):317–327. doi:10.1016/j.etp.2017.02.002
   PubMedGoogle Scholar
• Ciftci O, Turkmen NB, Taslıdere A. Curcumin protects heart tissue against irinotecan-induced damage in terms of cytokine level alterations, oxidative stress, and histological damage in rats. Naunyn Schmiedebergs Arch Pharmacol. 2018;391(8):783–791. doi:10.1007/s00210-018-1495-3
   PubMed Web of Science ®Google Scholar
• Sabet NS, Atashbar S, Khanlou EM, et al. Curcumin attenuates bevacizumab-induced toxicity via suppressing oxidative stress and preventing mitochondrial dysfunction in heart mitochondria. Naunyn Schmiedebergs Arch Pharmacol. 2020;393(8):1447–1457. doi:10.1007/s00210-020-01853-x
   PubMed Web of Science ®Google Scholar
• Huyut Z, Uçar B, Yıldızhan K, et al. The protective effect of curcumin on cardiac markers and fibrosis in abemaciclib-induced cardiac damage in rats. J Biochem Mol Toxicol. 2023;37(1):e23226. doi:10.1002/jbt.23226
   PubMed Web of Science ®Google Scholar
• Aziz SG, Pourheydar B, Chodari L, et al. Effect of exercise and curcumin on cardiomyocyte molecular mediators associated with oxidative stress and autophagy in aged male rats. Microvasc Res. 2022;143:104380. doi:10.1016/j.mvr.2022.104380
   PubMedGoogle Scholar
• Bazzazi H, Isenberg JS, Popel AS. Inhibition of VEGFR2 activation and its downstream signaling to ERK1/2 and calcium by thrombospondin-1 (TSP1): in. Silico Investigation Front Physiol. 2017;8:48.
   PubMed Web of Science ®Google Scholar
• Wahlström B, Blennow G. A study on the fate of curcumin in the rat. Acta Pharmacol Toxicol. 1978;43(2):86–92. doi:10.1111/j.1600-0773.1978.tb02240.x
   PubMedGoogle Scholar
• Ravindranath V, Chandrasekhara N. Metabolism of curcumin--studies with [3H]curcumin. Toxicology. 1981;22(4):337–344. doi:10.1016/0300-483X(81)90027-5
   PubMed Web of Science ®Google Scholar
• Carroll RE, Benya RV, Turgeon DK, et al. Phase IIa clinical trial of curcumin for the prevention of colorectal neoplasia. Cancer Prev Res (Phila). 2011;4(3):354–364. doi:10.1158/1940-6207.CAPR-10-0098
   PubMed Web of Science ®Google Scholar
• Pan MH, Huang TM, Lin JK. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metab Dispos. 1999;27(4):486–494.
   PubMed Web of Science ®Google Scholar
• Liu J, Huang YH, Wang BH, et al. Research progress on metabolic pathways and metabolites of curcumin compounds in vivo. Mod Med Clin. 2015;12:1553–1557.
   Google Scholar
• Hoehle SI, Pfeiffer E, Sólyom AM, et al. Metabolism of curcuminoids in tissue slices and subcellular fractions from rat liver. J Agric Food Chem. 2006;54(3):756–764. doi:10.1021/jf058146a
   PubMed Web of Science ®Google Scholar
• Ireson C, Orr S, Jones DJ, et al. Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E2 production. Cancer Res. 2001;61(3):1058–1064.
   PubMed Web of Science ®Google Scholar
• Hsu CH, Cheng AL. Clinical studies with curcumin. Adv Exp Med Biol. 2007;595:471–480.
   PubMed Web of Science ®Google Scholar
• Tanwar V, Sachdeva J, Kishore K, et al. Dose-dependent actions of curcumin in experimentally induced myocardial necrosis: a biochemical, histopathological, and electron microscopic evidence. Cell Biochem Funct. 2010;28(1):74–82. doi:10.1002/cbf.1623
   PubMed Web of Science ®Google Scholar
• Sun H, Zhu J, Lu T, et al. Curcumin-mediated cardiac defects in mouse is associated with a reduced histone H3 acetylation and reduced expression of cardiac transcription factors. Cardiovasc Toxicol. 2014;14(2):162–169. doi:10.1007/s12012-013-9240-0
   PubMed Web of Science ®Google Scholar
• Hanai H, Iida T, Takeuchi K, et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol. 2006;4(12):1502–1506. doi:10.1016/j.cgh.2006.08.008
   PubMed Web of Science ®Google Scholar
• Na LX, Li Y, Pan HZ, et al. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Mol Nutr Food Res. 2013;57(9):1569–1577.
   PubMed Web of Science ®Google Scholar
• Pourbagher-Shahri AM, Farkhondeh T, Ashrafizadeh M, et al. Curcumin and cardiovascular diseases: focus on cellular targets and cascades. Biomed Pharmacother. 2021;136:111214.
   PubMed Web of Science ®Google Scholar
• Ma T, Tian X, Zhang B, et al. Low-dose metformin targets the lysosomal AMPK pathway through PEN2. Nature. 2022;603(7899):159–165. doi:10.1038/s41586-022-04431-8
   PubMed Web of Science ®Google Scholar